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Abstract The effects of tetanus toxin (TeNT) both in the
spinal cord, in clinical tetanus, and in the brain, in exper-
imental focal epilepsy, suggest disruption of inhibitory
synapses. TeNT is a zinc protease with selectivity for
Vesicle Associated Membrane Protein (VAMP; previously
synaptobrevin), with a reported selectivity for VAMP2 in
rats. We found spatially heterogeneous expression of
VAMP1 and VAMP2 in the hippocampus. Inhibitory ter-
minals in stratum pyramidale expressed significantly more
VAMP1 than VAMP2, while glutamatergic terminals in
stratum radiatum expressed significantly more VAMP2
than VAMP1. Intrahippocampal injection of TeNT at doses
that induce epileptic foci cleaved both isoforms in tissue
around the injection site. The cleavage was modest at
2 days after injection and more substantial and extensive at
8 and 16 days. Whole-cell recordings from CA1 pyramidal
cells close to the injection site, made 8–16 days after
injection, showed that TeNT decreases spontaneous EPSC
frequency to 38 % of control and VAMP2 immunoreactive
axon terminals to 37 %. In contrast, TeNT almost com-
pletely abolished both spontaneous and evoked IPSCs
while decreasing VAMP1 axon terminals to 45 %. We
conclude that due to the functional selectivity of the toxin
to the relative sparing of excitatory synaptic transmission
shifts the network to pathogenically excitable state causing
epilepsy.
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Introduction
Tetanus neurotoxin (TeNT) is a remarkably potent Clos-
tridial toxin which in the spinal cord causes spastic
paralysis (Pellizzari et al. 1999), and in the forebrain epi-
leptic seizures (Yeh et al. 2010; Jefferys and Walker 2006).
Its light chain is a zinc protease selective for Vesicle
Associated Membrane Protein (VAMP; synaptobrevin),
while the heavy chain is necessary for uptake into neurons
(Schiavo et al. 2000). VAMP is essential for synaptic
transmission so that its proteolysis by TeNT, or by four of
the seven botulinum neurotoxins (BoNT/B, D, F and G),
causes loss of neurotransmitter release (Schiavo et al. 1992;
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Dolly et al. 2009). The remaining BoNTs target different
synaptic proteins, SNAP-25 and syntaxin, but also block
transmitter release. The clinical consequences of intact
TeNT (i.e. heavy and light chains linked by disulphide
bonds) differ from those of intact BoNT, which causes
flaccid paralysis in the spinal cord and BoNT/E has been
shown to have antiepileptic actions in the brain (Bozzi
et al. 2006). These observations suggest that extracellular
intact TeNT has specificity for inhibitory neurotransmis-
sion, as shown specifically in ‘‘synaptic bouton prepara-
tions’’ of isolated spinal neurons (Shin et al. 2012), while
BoNT causes a less specific block of synaptic transmission.
Intrahippocampal TeNT provides a chronic model of
temporal lobe epilepsy (TLE) characterised by intermittent
spontaneous seizures starting after a latent period of
*7 days (Jiruska et al. 2010, 2013; Jefferys 1989). The
diversity of clinical epilepsies argues for diverse experi-
mental models to investigate mechanisms and to develop
novel treatments. TLE is a common epilepsy that can be
difficult to treat pharmacologically. TLE can be subdivided
in various ways, for instance the presence and extent of
lesions such as hippocampal sclerosis. For most purposes
spontaneous seizures are an important feature of experi-
mental models (Stables et al. 2003). The TeNT model
differs from other spontaneously seizing rat TLE models in
lacking initial status epilepticus (prolonged epileptic sei-
zures) and produces minimal or no neuronal death in
70–90 % cases with highly focal lesions in the remainder
(Jiruska et al. 2010). We previously found that the inhibi-
tory neurotransmitter gamma aminobutyric acid (GABA)
release is disrupted within a few days, fully recovering by
8 weeks (Jefferys et al. 1991; Empson and Jefferys 1993;
Whittington and Jefferys 1994). The decrease in GABA
release during the active seizure phase was selective for the
Ca2?-dependent fraction (Jefferys et al. 1991). The lack of
changes in neuronal responses to exogenous GABA argues
for preservation of GABAA receptors (Whittington and
Jefferys 1994). More subtle inhibitory dysfunction per-
sisting at least 5 months (Vreugdenhil et al. 2002).
VAMP exists in multiple isoforms, VAMP1 and
VAMP2 occur widely in the brain and are involved in
synaptic transmission. VAMP2 is cleaved by TeNT (Chen
et al. 2012; Mainardi et al. 2012). While VAMP1 is
cleaved by BoNT/F (Verderio et al. 1999), it is reported to
be resistant to TeNT, at least in the rat (Schiavo et al. 1992,
1993). One hypothesis for the functional specificity of
TeNT (Shin et al. 2012) is that it has selectivity for a
VAMP isoform primarily expressed in GABAergic syn-
apses. Two alternative hypotheses are that the greater
activity of interneurons results in greater uptake of TeNT
(Williamson et al. 1992) or that the molecular determinants
of presynaptic uptake and intracellular trafficking select for
inhibitory synapses (Schiavo et al. 2000). In neocortex
VAMP2 occurs in up to twice as many excitatory terminals
as VAMP1, while both isoforms are equally represented in
inhibitory terminals (Bragina et al. 2010). Previous work
on changes in VAMP following intracortical injection of
TeNT has only examined VAMP2 and not VAMP1 (Mai-
nardi et al. 2012). Injection of a small amount of TeNT into
the hippocampus is extensively used as a model of tem-
poral lobe epilepsy (Jefferys and Walker 2006). Neo- and
archicortical areas differ in structure, cell types and func-
tions, so that extrapolation from neocortical data to explain
the toxin action in this temporal lobe epilepsy model can be
misleading and leaves the possibility open that cell specific
expression of VAMP isoforms may allow TeNT to selec-
tively target inhibitory neurons. In the present study, we
investigate the selectivity of expression of VAMP isoforms
in excitatory and soma-targeting inhibitory synapses in
hippocampus, and the impact of intrahippocampal injection
of TeNT on the presence of VAMP in the tissue and on
synaptic activity in brain slices over a period 2–16 days
after injection.
Methods
Animals and tetanus toxin injection
Adult male Sprague–Dawley rats weighing 220–280 g
were housed under standard conditions with temperature
controlled to 22 ± 1 C and 12/12 h light/dark cycle. The
animals had ad libitum access to food and water. All
experiments were performed under the Animals (Scientific
Procedures) Act 1986 of the United Kingdom and institu-
tional ethical review. Surgery was performed under iso-
flurane anaesthesia. One microliter of TeNT or vehicle
solution (0.05 M phosphate-buffered saline, PBS, Sigma
UK, with 2 % bovine serum albumin, BSA, Sigma UK)
was injected through a burr hole into the right hippocampus
into stratum radiatum of CA3, at coordinates 4.1 mm
caudal and 3.9 mm lateral to bregma and 3.8 mm below
cortical surface (Paxinos and Watson 1998), at 200 nl/min
using a Hamilton microsyringe and infusion pump
(KDS311, KD Scientific Inc., USA). The microsyringe was
left in place for 5 min to avoid backflow up the injection
track. Differences in potency of our stocks meant we
injected 25 ng of TeNT for the main immunohistochemical
studies (Sigma-Aldrich #B5002, Gillingham, UK) and
2.5–5.0 ng for electrophysiology and its associated
immunohistochemistry (#190A, Quadratech Diagnostic
Ltd, Epsom, UK). Analgesic (Buprenorphine, 1 ml/kg) was
injected intramuscularly during surgery. Animals were
housed individually.
Some rats were used to determine where seizures were
initiated with respect to the injection site. Following the
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injection, a square craniotomy was made centered at
-4.2 mm anterio-posteriorly and 3.1 laterally from bregma.
Twelve movable tetrodes were implanted through the cra-
niotomy into the neocortex above the dorsal hippocampus
(Fig. 7). Tetrodes were fabricated from tungsten wire
12 lm in diameter (H-Formvar insulation with Butyral
bond coat, California Fine Wire, Grover Beach, USA). The
tips of the electrodes were gold plated to reduce the elec-
trode impedance to \300 kX. Following the implantation,
craniotomy was sealed with paraffin. Reference and ground
electrodes were inserted into the bone above the cerebel-
lum. A microdrive assembly was then embedded in dental
cement and attached to the skull with anchoring screws.
After 1 week to allow recovery, electrodes were slowly
lowered into the hippocampus. Spontaneous brain activity
was recorded daily starting on day 8 and continued for
4 weeks. Each recording session lasted 2–8 h of continuous
recording. Signals were pre-amplified to minimize the
movement artifacts, amplified (1009 and 5009), band-pass
filtered at 0.1–5,000 Hz and digitised at 24 kHz using an
Axona recording system (Axona Ltd, St. Albans, UK).
For immunohistochemistry, animals were divided into
three survival groups: 2 days (6 TeNT; 3 controls), 8 days
(6 TeNT; 2 controls) and 16 days (6 TeNT; 2 controls).
None of the experimental measures in the controls differed
significantly between the three survival times (ANOVA,
P [ 0.05), so to meet obligations to minimize animal
numbers we pooled them for subsequent analyses. Animals
surviving 8 and 16 days were video-monitored continu-
ously from the 5th day postinjection using infrared digital
cameras (MSI 380i, Taipei City, Taiwan) and Spike 2
software (CED, Cambridge, UK) to verify the development
of spontaneous recurrent seizures. At the end of the
experiments animals were overdosed by anaesthetic (ket-
amine–medetomidine) and perfused transcardially with
4 C saline (0.9 % NaCl, Sigma, UK) followed by 4 %
paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.4,
Sigma, UK). Brains were extracted and postfixed 1 h in
4 % paraformaldehyde and then transferred into 0.1 M PB
for sectioning.
Histology and immunohistochemistry
For immunofluorescence labelling, 80-lm-thick coronal
sections were made using a vibratome (Model 1000 Pelco
Int., Redding, CA, USA). The sections were rinsed in
0.1 M PB (pH 7.4) 2 9 15 min to remove unbound fixa-
tive and washed in Tris buffer saline (TBS, 0.05 M, Sigma,
UK) 3 9 20 min containing 0.05 % Triton X-100 (pH 7.6).
Incubation of the sections in primary and secondary anti-
bodies was performed under continuous, gentle agitation at
4 C. For double immunolabelling pairs of commercially
available antibodies, polyclonal anti-VAMP1 (rabbit;
1:200, Abcam, Cambridge, UK), or anti-VAMP2 (rabbit,
1:1,000, Synaptic Systems, Goettingen, Germany) and anti-
GAD 65 (GAD-6) (mouse, 1:3,000 Abcam, Cambridge,
UK) or anti-VGLUT1 (guinea pig, 1:1,000, Chemicon,
Billerica, USA) and monoclonal anti-Neurofilament 68
clone NR4 (mouse, 1:400, Sigma, UK) were used. Anti-
bodies have been fully characterised and extensively used
previously in publications [e.g. VAMP1 (Coller et al.
2012); VAMP2 (Orenbuch et al. 2012)]. Slices were pre-
incubated in a blocking solution containing 5 % of normal
goat serum (Vector Laboratories, Peterborough, UK) in
TBS and 0.5 % Triton 100-X for 45 min at room temper-
ature to reduce nonspecific background labelling. Sections
were then incubated for 3 days at 4 C in the primary
antibodies at the dilutions stated above, in TBS containing
2 % normal goat serum and 0.5 % Triton X-100 and
washed with TBS, sections were incubated overnight at
4 C with secondary antibodies anti-rabbit Alexa Fluor 488
(1:1,000, Molecular Probes, Paisley, UK), CY3 conjugated
goat-anti-mouse (1:500, Molecular Probes, Paisley, UK) or
goat-anti-guinea pig CY3 (1:500; Jackson Immunore-
search, West Grove, USA). After three washes with PB,
sections were mounted on glass slides, air dried at room
temperature and coverslipped with homemade anti-fading
mounting media (Mowiol).
Imaging and analyses
Immunofluorescent labelling was investigated using 409
objective and high-resolution 16-bit grey scale images
were captured for signal intensity analyses using an
Olympus BX61 microscope equipped with an EXi Blue
(QImaging, Surrey, Canada) digital camera. The quantifi-
cation of the immunofluorescent labelling and colocaliza-
tion analyses were performed with the aid of image
acquisition and analyses software ImagePro Plus 7.0 and
the AutoQuant X, image deconvolution and 3D Visuali-
zation software (Media Cybernetics Inc, Bethesda, MD,
USA). To avoid signal fading and therefore altering signal
intensity of the immunofluorescent labelling in the final
preparations, care was taken to complete micro photo-
graphing in one session and to avoid exposing the sections
for prolonged periods to UV light or to repeat the capturing
process on the same slide.
Quantitative evaluation of immunofluorescent labelling
To estimate the intensity of immunolabelling and provide
comparable dataset for quantitative analyses, constant
exposure parameters (illumination strength, exposure time,
etc.) were preserved throughout the entire process within
and between animal groups. VAMP immunolabelling in
each slice was normalized by the labelling intensity in
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contralateral subiculum. This region was selected for nor-
malization because: (1) it consistently showed high label-
ling intensity; and (2) it lacks direct anatomical
connections with the injected hippocampus and should not
be affected by the toxin application. Normalized immu-
nolabelling was plotted distributed into eight bins of
intensity (grey scale). We analysed individual hippocampal
subregions (CA1, CA3, DG) of both hemispheres. The
number of pixels in each grey scale bin was plotted as a
percentage of the total surface (i.e. all bins) of the analysed
region. This process generated intensity spectrum graphs
for each region of each slice (Supplemental Figure 1). The
first moment mom1 of the grey scale spectrum is a weighted
average of the intensity of staining and was calculated
using the formula
mom1 ¼
P
f  I
P
I
where f is grey colour bin from grey colour spectrum and
I is its proportion it occupies from the total area.
Quantification of VAMP immunopositive boutons
The grey scale analysis of VAMP labelling has two limi-
tations: it is unlikely to be linearly related to levels of
VAMP in the tissue and it requires relatively large areas for
analysis. Therefore, we also quantified VAMP immunore-
active boutons. Z-stack images spanning the 2 lm from the
surface were acquired, underwent 3D deconvolution using
AutoQuant (MediaCybernetics, MD, USA) to reduce the
distortion and produce a clearer image, and then flattened
using Extended Depth of Field for maximum intensity to
obtain a single image (ImagePro Plus, MediaCybernetics,
MD, USA). Filters were applied to enhance the image and
aid the automatic counting of the boutons. A region of
interest (sized 100 lm2) was placed in four different areas
across the image, and the software automatically counted
the bright objects in the area followed by a watershed split
giving an output of all the different areas of the counted
boutons. Only those objects that were within the size range
of 0.1–0.7 lm2 were included in the analysis as boutons.
The number of boutons was measured in four regions of
interest for each image and averaged.
Colocalization analysis
Z-stack images covering 2 lm from the surface were
acquired, underwent 3D deconvolution using AutoQuant
(MediaCybernetics, MD, USA). To measure colocalization
between immunosignals at the single bouton level line
histograms were created in randomly chosen areas in or
adjacent to the pyramidal cell layer. Quantitative colocal-
ization measurements used for statistical analysis were
performed on each pixel in the area of interest. To prevent
false positive and negative results due to photobleaching
(slices at the bottom of the stack) and overexposure (slices
at the top of the stack) multiple ([15) optical stacks were
taken from the top 2 lm and an average of five individual
optical slices from each Z stack of images were used for
quantitative colocalization analysis. Measurements were
performed only once on a given area. ImagePro’s built-in
colocalization algorithm was used to measure Pearson’s
coefficient to evaluate colocalization at the population
level, and line measurement to analyse colocalization at the
bouton level (ImagePro Plus, MediaCybernetics, MD,
USA). The quantitative colocalization analysis was per-
formed on the entire optical section without defining any
area of interest.
Electrophysiology
Electrophysiology was performed 8–16 days following
TeNT injection, when the changes in VAMP immunohis-
tochemistry were greatest. Animals were anaesthetized by
ketamine/medetomidine and transcardially perfused with
sucrose solution. Brains were removed and 300-lm coronal
hippocampal slices were prepared and placed in a holding
chamber. For recording, slices were transferred to a sub-
merged chamber. Whole-cell patch-clamp recordings were
made from the somata of CA1 pyramidal neurons from the
CA2 and subicular ends of the CA1 region of ipsilateral
and contralateral hippocampi. Electrophysiological
recording started 10 min after establishment of the whole-
cell configuration. Pyramidal neurons were identified using
an infrared differential interference contrast on an Olympus
BX-51 upright microscope, fitted with a fluorplan 409, 0.8
NA water immersion lens (Micro Instruments, Long Han-
borough, UK). CA1 neurons were visually selected based
on appearance and the integrity of the apical dendrites
(visible for *100 lm from the soma). Patch electrodes
were pulled from borosilicate glass (OD 1.2 mm, ID
0.69 mm; Harvard Apparatus, Edenbridge, UK) using a
P-97 puller (Sutter, Novato, CA, USA). The intracellular
solution comprised (mM); 135 CsCH3SO4, 8 NaCl, 10
HEPES, 5 QX-314, 2 Mg-ATP and 0.3 Na-GTP; pH 7.3
with KOH (osmolarity *285 mOsm); 0.5 % neurobiotin
enabled identification of the recorded cell and correlation
of its synaptic activity with loss of VAMP1 and 2. EPSCs
were recorded at -75 mV to avoid contamination by
IPSCs, and were confirmed as EPSCs by their abolition by
20 lM NBQX and 25 lM D-APV (not shown). IPSCs were
recorded at 0 mV to avoid contamination by EPSCs, and
were confirmed as IPSCs by their abolition by 10 lM
bicuculline (not shown). Patch electrodes typically had
resistances of 4–7 MX. Membrane potentials and currents
were recorded using an NPI SEC-10L amplifier
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(Scientifica, Harpenden, UK) or Axoclamp 2 (Molecular
Devices, Sunnyvale, CA, USA), low-pass Bessel filtered at
1 kHz (NL-125, Digitimer Ltd, Welwyn Garden City, UK)
and digitised at 10 kHz by a Power 1401 (CED Ltd,
Cambridge, UK). Stimulation and data acquisition were
controlled using Signal software (version 3; CED). Evoked
postsynaptic currents were generated using a glass stimu-
lating electrode placed in stratum radiatum (*50 lm from
stratum pyramidale and 50 lm from the recorded cell).
Spontaneous synaptic events were analysed using Mini-
Analysis (version 6.0.3, Synaptosoft, Decatur, GA, USA).
The threshold for synaptic event detection was set at 59
root mean baseline square noise, which averaged
2.97 ± 0.20 pA.
Immunohistochemical analysis of in vitro slices
After recording, slices were incubated in 4 % PFA for
1.5 h, then washed in 0.1 M PB and stored in 0.1 M PB
with thimerosal (1:1,000) at *4 C before sectioning.
Each 300-lm slice was resectioned to 80 lm using a Vi-
bratome (Model 1000 Pelco Int., Redding, CA, USA) and
stored in 0.1 M PB and thimerosal (1:1,000) before
immunohistochemistry (VAMP1, VAMP2, neurobiotin).
Sections to be incubated with the VAMP1 antibody
underwent a further 5 h incubation in 4 % paraformalde-
hyde to achieve optimal staining. The staining procedure
was carried out in the same way as above, with the addition
of streptavidin conjugated Alexa 546 (1:200) to the sec-
ondary antibody solution, to visualise neurobiotin in
recorded cells. After immunolabelling for VAMP and
neurobiotin, low magnification images were taken of the
VAMP1/2 labelling and the position of the neurobiotin-
containing cell. This was followed by high magnification
images using an oil immersion lens around the portion of
the stratum radiatum directly adjacent to stratum pyrami-
dale and the labelled cell.
Statistical analyses
The statistical analyses specified in the text were applied
using SPSS software, with a significance criterion of 0.05.
Results are expressed as a mean and standard error of the
mean (SEM) unless otherwise stated.
Results
Behavioural effect of tetanus toxin injection
It is already well established that injecting TeNT into rat
hippocampus induces epilepsy with a latency of approxi-
mately 7 days following the injection. Seizure semiology
in the present study corresponded to complex partial sei-
zures of limbic origin with secondary generalization as
described previously (Finnerty and Jefferys 2000): epi-
sodes of prolonged staring, orofacial automatisms followed
by forelimb clonus, rearing, falling and generalised tonic–
clonic movements and frequently followed by wet dog
shakes.
Distribution of the VAMP1 and VAMP2 protein
in the rat hippocampus
The two isoforms had distinctive, but overlapping, distri-
butions in the hippocampal formation of control rats. At
low magnification VAMP1 showed high labelling intensity
(bright signal) in the strata oriens and radiatum of CA1 and
CA3 and the inner molecular layer of dentate gyrus (DG).
VAMP1 immunolabelling was weak in the hippocampal
fissure, in stratum lacunosum moleculare of CA1 and outer
molecular layer of DG (darker layers, Fig. 1a). VAMP2
immunolabelling was more evenly distributed than
VAMP1 (compare panels A in Figs. 1 and 3). Labelling of
VAMP2 was greater in the dendritic layers of CA1, CA3
and DG, especially in CA1 stratum lacunosum molecular
and DG outer molecular layer, with almost no variations in
labelling intensity throughout the rostro-caudal axis of the
hippocampus. VAMP2 also was particularly strong in
stratum lucidum of the CA3 indicated by the presence of a
discrete band of intensely labelled axon terminals, pre-
sumably deriving from mossy fibres adjacent to the CA3
pyramidal layer (Fig. 2a). The intensity of VAMP2 im-
munolabelling was low in the stratum pyramidale of CA1
and CA3. The weakest labelling of both isoforms was in
the granule cell layer of the DG.
Spatiotemporal profile of tetanus toxin action
on VAMP1
Injection of TeNT resulted in decreased VAMP1 labelling
(Figs. 1b, c, 3). Two days after TeNT injection, the loss of
VAMP1 was modest and highly localized close to the
injection site, so that it mostly affected CA3 and adjacent
parts of CA1 and DG in the rostral hippocampal section
(not shown). The loss of VAMP1 became more substantial
and extensive (2.5 ± 0.2 mm, n = 5) eight days after
injection (Figs. 1b, c, 3) and started to recover by 16 days
(Fig. 3). The TeNT-induced decrease in VAMP1 can be
assessed by the labelling-intensity spectrum graphs by a
shift of the peaks towards darker bins from those for
controls. To quantify the spatiotemporal profile we calcu-
lated the first moment of the labelling-intensity spectra
(Fig. 3). Results showed that loss of VAMP1 appeared by
2 days in rostral CA3 and CA1, and decreased further by
day 8 (Fig. 3a). The loss is sustained at day 16, but started
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to recover in the middle section CA1 and CA3 (Fig. 3a).
This spatiotemporal profile is consistent with the first loss
of signal appearing close to the injection site and then
spreading to the dentate gyrus and to the caudal sections
through the hippocampus (Fig. 1b). There is no evidence of
changes in VAMP1 immunostaining intensity contralateral
to the injection (Fig. 2d, e).
Spatiotemporal profile of tetanus toxin action
on VAMP2
The effects of TeNT on VAMP2 expression 8 days after
injection are shown in Fig. 2. By this stage the area of
reduced VAMP2 signal covered large parts of ipsilateral
CA1 and CA3, and the lateral parts of DG (Fig. 2b, c), and
there is some evidence of decreased VAMP2 contralater-
ally, particularly in caudal CA3 (Fig. 2d). The analysis of
spatiotemporal changes in VAMP2 (Fig. 4) shows that the
decrease of the immunosignal starts later than 2 days
postinjection, first being seen at day 8 in CA1 and CA3 of
rostral ipsilateral sections, extending to all regions by
day 16.
Neuronal specific expression of VAMP1 and VAMP2
We investigated the neuronal specificity of the expression
of the two VAMP isoforms. Excitatory and inhibitory cells
and their synapses can be directly characterised by the
presence of specific transmitter synthesizing or transporting
enzymes, VGLUT1 and GAD65, respectively. To differ-
entiate VAMP1 and VAMP2 expression between excit-
atory and inhibitory axon terminals we performed double
immunolabelling for each VAMP isoform and GAD65 (for
inhibitory) and VGLUT1 (for excitatory). Cellular differ-
ences in the expression of the two isoforms were found in
CA3 (Fig. 5) and CA1. VAMP1 strongly co-localized with
GAD65 positive boutons, particularly in the mainly soma-
targeting boutons of stratum pyramidale, which play a key
Fig. 1 VAMP1
immunofluorescent labelling in
control and TeNT-treated
hippocampus. a Distribution of
VAMP1 in normal dorsal
hippocampus. b Depletion of
VAMP1 in the middle parts of
the hippocampus 8 days after
the tetanus toxin (TeNT)
injection. Dashed lines mark the
approximate area of decrease in
VAMP1 labelling. c On day
eight the VAMP1 deficit is
observable also in caudal parts
of the injected dorsal
hippocampus. Middle (d) and
caudal parts (e) of contralateral
hippocampus are not affected by
VAMP1 deficit. Scale bar
(a) 1 mm
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role in regulating pyramidal cell firing and hence in epi-
lepsy (Fig. 5a). We performed automated quantitative
image analysis both at single bouton and bouton population
levels. These analyses revealed high level of colocalization
(Pearson’s coefficient 0.456 ± 0.015; n = 52; Fig. 6
optical sections from 3 animals, 2 sections each, sampled
evenly from each rat) in the perisomatic region, where
inhibitory terminals effectively regulate Na? spike genesis
of excitatory neurons (Fig. 6). In contrast, VAMP1 im-
munolabelling infrequently coincided with VGLUT1
immunostained profiles (Pearson’s coefficient
0.231 ± 0.016, n = 58; Fig. 6) in stratum radiatum where
excitatory terminals are located (Figs. 5b, 6). VAMP2
expressing synaptic terminals were predominantly
VGLUT-1 positive (Pearson’s coefficient 0.542 ± 0.015,
n = 59) (Figs. 5d, 6), and infrequently found to express
GAD65 (Pearson’s coefficient 0.044 ± 0.023, n = 60)
(Figs. 5c, 6). The neuron specific expression of VAMPs
shown by these correlations differed significantly showing
that GAD65 correlated significantly more strongly with
VAMP1 than VAMP2, and that VLUT1 correlated signif-
icantly more strongly with VAMP2 than VAMP1
(P \ 0.0001 in both cases, unpaired t tests, Fig. 6). The
highest density of VAMP2 immunopositive axon terminals
was in stratum lucidum, which contains the mossy fibre
excitatory input onto CA3 pyramidal cells (Figs. 2d, 5d).
These results indicate that VAMP1 is expressed preferen-
tially but not exclusively in soma-targeting inhibitory
synapses, while VAMP2 is primarily associated with
excitatory boutons.
Functional consequences of tetanus toxin injection
on synaptic transmission
The loss of both VAMP1 and VAMP2 suggests that both
excitatory and inhibitory neurotransmission would be lost.
This appears inconsistent with the evidence in vivo: epi-
lepsy in this model and spastic paralysis with clinical
Fig. 2 VAMP2
immunofluorescent labelling in
control and TeNT-treated
hippocampus. a Distribution
VAMP2 in the dorsal
hippocampus of control
animals. b Deficit in VAMP2
immunolabelling in the middle
part of the hippocampus 8 days
following the tetanus toxin
(TeNT) injection. Dashed lines
mark the approximate area of
decrease in VAMP2
immunolabelling. Stars mark
the glial scar after the needle
track. c On day eight the
VAMP2 deficit also is
observable in caudal parts of the
injected hippocampus. Middle
(d) and caudal parts (e) of
contralateral hippocampus do
not show VAMP2 depletion.
Scale bar 1 mm
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tetanus. It also appears inconsistent with earlier reports on
synaptic responses in vitro following intrahippocampal
TeNT (Jefferys 1989; Jordan and Jefferys 1992) and with
more recent work on spinal neurons (Shin et al. 2012).
Given the spatial distribution of changes in VAMP fol-
lowing TeNT injection we first made chronic in vivo
recordings from a closely spaced array of metal micro-
electrodes revealed seizures initiating within 300–450 lm
of the injection site (recordings 13 days after injection are
shown in Fig. 7). This shows that the VAMP-depleted area
around the injection site, spanning *2.5 mm, was capable
of initiating and sustaining seizures, and that this area’s
cellular electrophysiology is directly relevant to the epi-
leptic syndrome.
We prepared hippocampal slices for electrophysiology
8–16 days after intrahippocampal TeNT injection, made
whole-cell recordings from pyramidal neurons which were
filled with Alexa (Fig. 8a) and counted the number
VAMP1 and VAMP2 boutons close to the recorded neu-
rons (Fig. 8b–e) to correlate the morphological and func-
tional measures. In CA1 close to the injection site (CA1c,
adjacent to CA3 and inside the area of VAMP cleavage)
evoked EPSCs were substantially reduced, to 22 % of
control values while IPSCs were abolished (Fig. 8f and h,
respectively). Neither measure was affected in CA1a,
which is outside the zone of VAMP depletion (Supple-
mental Figure 2; Supplemental Table 1). To improve the
quantification of synaptic function we then recorded
spontaneous EPSCs and IPSCs in CA1c. The amplitudes of
both types of spontaneous event were not affected by TeNT
(Supplemental Table 2), but the frequencies were sub-
stantially reduced (Fig. 8g, i). Spontaneous IPSCs fell to
very low frequencies, *2 % of control, while spontaneous
EPSCs fell to *38 % of control (Fig. 8j, k). The relative
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Fig. 3 Spatiotemporal changes in VAMP1 immunofluorescence.
a Temporal changes of the first moment of VAMP1 immunolabelling
intensity in individual hippocampal subregions of middle parts of the
injected hippocampus. In CA3 and CA1 the shift towards the darker
bins is present on day 2 suggesting loss of VAMP1 immunosignal.
b Temporal profile of changes of the first moment of the labelling
intensity in caudal parts of ipsilateral hippocampus. First changes
occur on day 8. c Grey scale map representation of the mean values of
the first moments of VAMP1 immunolabelling intensity in individual
regions of ipsilateral and contralateral hippocampi of control animals.
d Grey scale plot of mean values of first moments of VAMP1
immunolabelling in TeNT animals during day 2, 8 and 16. It
demonstrates early shift towards lower values of the first moments
(darker colours) in ipsilateral middle parts of the hippocampus and
later decrease in VAMP1 immunolabelling in caudal parts of the
hippocampus
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preservation of EPSCs provides a plausible explanation of
the epileptic syndrome, but it raises the question of whether
this can be explained by a preservation of VAMP2 in a
subset of boutons. We therefore measured the density of
VAMP1 and VAMP2 labelled boutons close to the tracer-
labelled neurons in the slices used for the electrophysiol-
ogy. In CA1c, close to the injection, VAMP1 decreased to
50 % of control (P = 0.001) and VAMP2 decreased to
53 % (P = 0.023). Both evoked and spontaneous PSC
frequency positively correlated with the density of VAMP
boutons (spontaneous PSCs are shown in Fig. 8j, k;
VAMP1-sIPSCs, r2 = 0.97, P = 0.01; VAMP2-sEPSCs,
r2 = 0.95, P = 0.01; evoked EPSCs are shown in Sup-
plemental Figure 1 and Supplemental Table 1).
In contralateral CA1 no statistical significant deficit was
observed in any of the functional measures characterizing
excitatory and inhibitory transmission (Supplemental
Tables 1, 2). The density of VAMP1 and VAMP2 boutons
did not differ between TeNT-injected animals and controls,
nor between CA1c and CA1a areas (data not shown). We
also determined the bouton density for CA3 bilaterally
8-16 days after injection. TeNT decreased ipsilateral
VAMP1 and VAMP2 significantly (respectively to 55 and
65 % of control; P \ 0.001 and P = 0.001). In contrast
with the measurements for CA1, in CA3 contralateral to
the TeNT injection the median VAMP1 bouton density
decreased significantly to 76 % of control (P = 0.009,
Mann–Whitney rank sum) and the median VAMP2
decreased to 65 % of control (P = 0.001, Mann–Whitney
rank sum).
Increased VAMP1 expression in inhibitory cell somata
We observed VAMP1 immunopositive somata within the
region of depletion of synaptic VAMP1 in the vicinity of
the TeNT injection (Fig. 9). A total of 1,807 VAMP1
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Fig. 4 Spatiotemporal changes in VAMP2 immunofluorescence.
a Temporal changes of the first moment of VAMP2 immunolabelling
intensity in individual subregions of the middle dorsal hippocampus.
Shift towards the lower mean values of the first moment correspond to
decrease in VAMP2 immunolabelling. The decrease is most pro-
nounced on days 8 and 16. b Temporal profile of changes of the first
moment of VAMP2 immunolabelling intensity in caudal parts of
ipsilateral hippocampus. First changes occur on day 16 in CA3.
c Grey scale map representation of the mean values of the first
moments of VAMP2 immunolabelling intensity in individual regions
of ipsilateral and contralateral hippocampi of control animals. d Grey
scale plot of mean values of first moments of VAMP2 immunola-
belling in TeNT animals during day 2, 8 and 16. Shifts towards low
values of the first moments (darker colours) are present in ipsilateral
hippocampus and while contralateral hippocampus is spared
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expressing cell bodies were identified from 120 hippo-
campal sections prepared from all three survival times
following TeNT injection. No VAMP1 immunopositive
somata were present in control tissue or in regions remote
from the injection site in rats treated with TeNT. These
VAMP1-positive somata appeared in all hippocampal
subregions as long as they were within the area of toxin-
induced loss of VAMP (Fig. 9d). In some cases major
Fig. 5 Neuronal specific expression of VAMP1 and VAMP2
assessed by colocalization with putative inhibitory (GAD65) and
excitatory (VGLUT1) markers in control animals. a Immunofluores-
cent microphotographs depict strong colocalization between VAMP1
and GAD65 immunolabelled axon terminals. b VAMP2 and GAD65
positive axon terminals show large degree of spatial segregation in
strata pyramidale and lucidum. c VAMP1 and VGLUT1 immuno-
positive terminals show weak colocalization in the strata lucidum and
pyramidale. d Immunolabelling for VAMP2 and VGLUT1 terminals
demonstrate strong colocalization particularly in stratum lucidum. pyr
stratum pyramidale, luc stratum lucidum, rad stratum radiatum. Line
profile analysis in the fourth row indicates signal overlap between
VAMP1-GAD65 and VAMP2–VGLUT1 double immunolabelled
axon terminals, and spatial segregation of VAMP1-VGLUT1 and
VAMP2-GAD65 immunoreactive boutons. Blue bars on the com-
posite microphotographs (row 3) show the site and length of line
measurement. Coloured scatter plots in the bottom row represent
distribution of co-localizing pixels according to intensity in the CA1
strata pyramidale and radiatum, respectively. Scale bar 20 lm
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dendrites were also immunopositive for VAMP1 (Fig. 9a–
c). The greatest number of labelled cells (27.0 ± 7.4) was
observed in rostral sections of the day 8 group (Fig. 9e). In
the caudal hippocampus the largest number of labelled
somata (22.5 ± 3.4) was reached 16 days after toxin
injection (Fig. 8f). VAMP1 expressing cell bodies were
found principally in the stratum pyramidale, at the border
of the strata radiatum and pyramidale and occasionally in
strata oriens and lacunosum moleculare in CA1 and CA3
(Fig. 9d). In dentate gyrus they were located at the
molecular layer and at the border of the granule cell layer
and in the hilus (Fig. 9a, b).
The majority of VAMP1 positive cells were character-
ised by round, occasionally elongated cell bodies (Fig. 9a–
c), and dendrites were aspiny with a beaded appearance
especially at their thinner distal regions. Based on their
morphological features 98 % of the analysed cells could be
classified as inhibitory neurons, including likely basket
cells which were common in strata pyramidale and radia-
tum. This was confirmed by colocalization of GAD65 in
87 % of the VAMP1 positive cell bodies (only 6 % showed
no clear colocalization with GAD65).
We tested whether VAMP1 accumulation in somata and
dendrites resulted from damage to axoplasmic transport by
double immunolabelling for VAMP1 and neurofilament
68k, the anatomical substrate of the intra axonal transport
system (Fig. 10a, b). Immunolabelling showed loss of
VAMP1 but no change in neurofilament immunolabelling,
even in the centre of the VAMP depletion zone close to the
injection site. Thus, accumulation of VAMP1 in inhibitory
cell somata is most likely the result of enhanced protein
synthesis rather than damage of transport.
Survival of synaptic terminals after VAMP cleavage
by tetanus toxin
Depletion of both isoforms of VAMP occurs close to the
site of TeNT injection by day 2, although only in the case
of VAMP1 is this extensive enough to be detected by the
grey scale analysis. Immunolabelling of this focal region of
cleavage reveals near-complete loss of both VAMP1 and
VAMP2 (Fig. 10c, d). However, in both cases VGLUT and
GAD65 expression is preserved, suggesting that the pre-
synaptic terminals of both excitatory and inhibitory neu-
rons survive loss of VAMPs.
Discussion
Our immunohistochemical observation of the distribution
of VAMP isoforms in the hippocampus extends previous
reports on expression in the brain as a whole (Raptis et al.
2005). The spatial separation of inhibitory and excitatory
inputs in the hippocampus allowed us to determine the
coexpression of each VAMP isoform with specific markers
for excitatory and inhibitory synapses, quantifying the
correlations of the pairs of proteins (Bolte and Cordelieres
2006). We analysed the VAMP expression in inhibitory
terminals in the perisomatic region where the axon termi-
nals are almost exclusively inhibitory and predominantly
from basket cells, while the VAMP expression of excit-
atory boutons were analysed in stratum radiatum, adjacent
to stratum pyramidale, where the excitatory Schaffer col-
laterals dominate the input. We found much more prevalent
expression of VAMP1 than VAMP2 in hippocampal
pyramidal layer inhibitory synapses (Fig. 6) contrasting
with the near-identical colocalization of the two VAMP
isoforms in neocortical inhibitory synapses (Bragina et al.
2010). VAMP2 was predominantly expressed in excitatory
synapses in the hippocampus, similar to the neocortex
(Bragina et al. 2010). The difference between hippocampal
and neocortical inhibitory synapses could be due to: the
more specific sampling of soma-targeting synapses in the
hippocampus, or to neocortical and hippocampal synapses
having different biochemical machinery for GABA release
(Sugino et al. 2006), or to the different inhibitory cell
markers used in the two studies, respectively GAD and
VGAT (Bragina et al. 2010). A lack of VGAT expression
has been reported for some GABA-expressing neurons
(Chaudhry et al. 1998; Zhao et al. 2011; Jarvie and Hentges
2012).
Pe
ar
so
n'
s 
Co
rre
la
tio
n 
Co
ef
fic
ie
nt
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
***
***
VAMP1+
GAD65
VAMP2+
GAD65
VAMP1+
VGLUT1
VAMP2+
VGLUT1
Fig. 6 Quantitative analysis of coexpression of VAMP1, VAMP2,
GAD65 and VGLUT1 protein in axon terminals. Pearson’s correla-
tion is shown for each VAMP isoforms double labelled with GAD65
and VGLUT1, respectively. Significantly higher overlap was detected
of VAMP1–GAD65 labelling compared to VAMP2 isoform
(***P \ 0.0001, unpaired t test, r2 = 0.79). Colocalization between
VAMP2–VGLUT1 was significantly higher than VAMP1–VGLUT1
(***P \ 0.0001, unpaired t test, r2 = 0.77). Data are given as
mean ± SEM
Brain Struct Funct (2015) 220:1013–1029 1023
123
In the present study intrahippocampal injection of TeNT
caused substantial focal reductions in both VAMP1 and
VAMP2, providing evidence that rat VAMP1 can indeed
be a substrate for TeNT in rat brain, in contrast with pre-
vious reports (Schiavo et al. 1993) which continue to
inform work on the topic (Chen et al. 2012; Mainardi et al.
2012). The depletion by TeNT of both VAMP1 and
VAMP2 to similar degrees argues against another
hypothesis for the clinical effects of the toxin, that greater
uptake into the more rapidly firing inhibitory neurons can
explain a selective effect of TeNT on inhibitory transmis-
sion (Williamson et al. 1992), however, this conclusion
must be qualified by the unreliability of comparing two
different proteins by the binding of two different antibod-
ies. VAMP1 is depleted close to the injection track a few
days before VAMP2 (compare Figs. 3 and 4), but epileptic
seizures start, within the zone of depleted VAMP, after day
8 when both isoforms have decreased. TeNT uptake does
depend on synaptic activity exposing the SV2, to which the
toxin binds, to the extracellular space (Yeh et al. 2010), so
neurons need to be active, which they are in vivo. Given
that some classes of interneuron fire at much higher fre-
quencies than pyramidal cells the results of Williamson
et al. (1992) and Yeh et al. (2010) would be consistent with
a greater effect of TeNT on inhibition. Curiously, a recent
report on acute applications of TeNT to neocortical neu-
rons in culture described a more rapid loss of miniature
EPSCs than IPSCs (Yeh et al. 2010). Heterogeneity in
expression of major protein families (Sugino et al. 2006)
might explain the difference between our study and Yeh’s
report (2010).
The model has a sequence of stages, as shown by pre-
vious physiological studies (Whittington and Jefferys
1994). Postsynaptic receptor changes have not been
extensively investigated, but we do know that responses to
exogenous GABA do not change at any stage of the model
(Whittington and Jefferys 1994) and that GluR2 receptors
show a transient increase in their flip isoform 4 weeks after
TeNT injection (Rosa et al. 1999), later than the period
covered by the present study. Intrinsic properties of neu-
rons have not been extensively reported in this model: at
several months there is evidence of decreased excitability,
1-4
2-5
3-6
4-7
5-8
6-9
7-10
8-11
9-12
1 2 3
4 5 6
7 8 9
10 11 12lambda
bregma
1-4
2-5
3-6
4-7
5-8
6-9
7-10
8-11
9-12
1-4
2-5
3-6
4-7
5-8
6-9
7-10
8-11
9-12
10 s 5 mV
200 ms
5 mV
400 ms
5 mV
100 ms
5 mV
B
D E
C D
1-4
2-5
3-6
4-7
5-8
6-9
7-10
8-11
9-12
A
C
*
Fig. 7 Spatial profile of epileptic activity in freely moving animals.
a Schematics of tetrode spatial organization in relation to the site of
TeNT injection. b Recording 13 days after injection shows sponta-
neous seizures, which involves most of the recording area. A bipolar
montage was derived from the reference-mode recording to reveal
locally generated activity. Seizures are generated across most of the
recording area. c Seizure onset is characterised by the presence of
slow field potentials with superimposed high-frequency activity at
*280 Hz. Seizure onset site is marked by star. d Detail of advanced
part of seizure. e High-amplitude discharges with superimposed high-
frequency oscillations ([240 Hz) are present between seizures
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probably related to decreased densities of Na? channels
(Brace et al. 1985; Vreugdenhil et al. 2002), but action
potentials look qualitatively normal during the active sei-
zure phase both in pyramidal cells (Jefferys 1989) and
interneurons (G.L. Morris, A.D. Powell, P. Jiruska and
J.G.R. Jefferys, unpublished). The initial stage of the direct
action of the toxin may induce adaptive changes, including
increased production that could produce the VAMP1
accumulation in somata reported here. This could be rela-
ted to the increase in GAD mRNA found around 4 weeks
Fig. 8 Electrophysiology in
CA1c pyramidal cells
8–16 days after injection.
a Recovered pyramidal cell
labelled with biocytin during
recording (scale 50 lm, dashed
lines pyramidal layer, dashed
box area of photomicrographs
on c/e). b VAMP1
immunolabelled axon terminals
in stratum radiatum adjacent to
labelled pyramidal cell in
control tissue (slices resectioned
for histology; four regions of
interest (10 lm2, size of dashed
box) were positioned and
boutons were detected and
counted). c VAMP1
immunoreactive boutons in
TeNT-injected rat (as in b).
d VAMP2 immunostained axon
terminals in control tissue as in
b. e VAMP2 immunostaining in
treated animal, as in c. f,
g Evoked and spontaneous
EPSCs reveal considerable
reductions following injection
of TeNT (red traces). h,
i Evoked and spontaneous
IPSCs reveal near-abolition of
following injection of TeNT. j,
k Reductions in frequencies of
spontaneous synaptic events
correlate strongly with the
corresponding VAMP
immunopositive bouton count
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after TeNT injection (Najlerahim et al. 1992), with both
changes contributing to the restoration of transmitter
release from inhibitory synapses found at later stages in the
model (Whittington and Jefferys 1994).
In the present study, we have explicit evidence of a selec-
tive disruption of inhibition and relative sparing of excitation
within the tissue exposed to the effects of TeNT. Between days
8 and 16 we found that inhibitory synaptic transmission close
to the injection site was reduced to *1 % of control, while
excitatory synaptic activity was present, but reduced to 23 %
of control. Neurons outside the zone of VAMP depletion
retained normal inhibitory and excitatory synaptic activity.
Fig. 9 VAMP1 overexpression
and accumulation in inhibitory
cell somata after TeNT
injection. a, b VAMP1
immunolabelling identifies cells
with high levels of VAMP1
expression in the somata in the
dentate gyrus of the TeNT-
injected hippocampus (arrows).
c Double immunohistochemical
labelling shows high degree of
colocalization of VAMP1 and
GAD65. Arrows indicate
colocalization, arrowheads
occasional lack of
colocalization between the two
signals. d Spatiotemporal
distribution of the VAMP1
immunopositive cell bodies.
They appeared frequently
around the area of VAMP1
depletion (dashed lines). e,
f Spatiotemporal distribution of
the numbers of VAMP1
overexpressing cells in rostral
(e) and caudal parts of the dorsal
hippocampus (f). Scale bars
a 100 lm, b, c 50 lm
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The relative selectivity of TeNT for inhibitory, and
relative sparing of excitatory, transmission would explain
the clinical and experimental consequences of TeNT in
the CNS. However, the loss of VAMP2 immunolabelling
quantified by numbers of positive boutons is about the
same as the loss of VAMP1 positive. In both cases the
frequency of spontaneous PSCs correlates with the den-
sity of the corresponding VAMP boutons, but the rela-
tionship is steeper for sIPSCs and VAMP1, and
importantly approaches zero IPSCs with exposure to
TeNT. The reasons for the differences in relationships
between synaptic currents and the respective VAMP iso-
forms are unclear: comparing two proteins by immuno-
histochemistry is unsafe because the binding
characteristics may differ considerably, but different
classes of neuron can differ in their release machinery
(Song et al. 2013) and it is possible that sensitivities to
VAMP depletion may also differ.
The present study questions previous work predicting that
rat VAMP1 should not be sensitive to TeNT (Schiavo et al.
1992, 1993). It demonstrates that VAMP1 is mainly in
inhibitory boutons and VAMP2 is mainly in excitatory. The
relative sparing of spontaneous EPSCs is surprising given the
similar degrees of depletion of both VAMP1 and VAMP2,
but is related to a steeper relationship following exposure to
TeNT of spontaneous IPSCs with density of VAMP1 posi-
tive terminals than of EPSCs with density of VAMP2 ter-
minals. This relative sparing of EPSCs provides a basis for
the initial stages of the TeNT model of focal epilepsy and, if
replicated in motor structures, may help to explain the spastic
paralysis characteristic of tetanus intoxication.
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Fig. 10 TeNT cleaves VAMPs but neither neurofilament nor
enzymes related to production and packaging of neurotransmitters.
a Double immunofluorescent labelling of Neurofilament 68 k (NF,
a1) and VAMP1 (a2) in control hippocampus. b TeNT injection
causes loss of VAMP1 immunosignal (b1) but does not affect NF
expression (b2). c Double immunofluorescent labelling illustrates
selective cleavage of the VAMP1 (c1) while GAD65 expression is
unaffected (c2, c3). Note VAMP1 immunolabelled soma (open arrow
c1, c3) despite lack of VAMP1 positive axon terminals. d1–d3 TeNT
injection also depletes VAMP2 without loss of VGLUT1 expression;
somata are not labelled with VAMP2. ori stratum oriens, pyr stratum
pyramidale, luc stratum lucidum, rad stratum radiatum. Scale bar
20 lm
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